<p>Supemtek Tetra is a vaccine used to protect adults and children from 9 years of age against influenza (flu).</p><p>Influenza is mainly caused by two kinds of influenza virus, known as influenza A and B. Each of these circulate as different strains and subtypes, which change over time.</p><p>Supemtek Tetra contains proteins of four different influenza A and B virus strains (type A-H1N1, type A-H3N2 and two type B strains), chosen based on the official recommendation for the annual flu season.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Supemtek Tetra is indicated for active immunization for the prevention of influenza disease in adults and children from 9 years of age and older. <br><br>Supemtek Tetra should be used in accordance with official recommendations.</p></div>
Therapeutic Area (MeSH)
ATC Code
J07BB02
ATC Item
N/A
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Influenza A virus subtype H1N1 haemagglutinin, recombinant | N/A | Influenza A virus subtype H1N1 haemagglutinin, recombinant |
| Influenza A virus subtype H3N2 haemagglutinin, recombinant | N/A | Influenza A virus subtype H3N2 haemagglutinin, recombinant |
| Influenza B virus Victoria lineage haemagglutinin, recombinant | N/A | Influenza B virus Victoria lineage haemagglutinin, recombinant |
| Influenza B virus Yamagata lineage haemagglutinin, recombinant | N/A | Influenza B virus Yamagata lineage haemagglutinin, recombinant |
EMA Name
Supemtek Tetra (previously Supemtek)
Medicine Name
Supemtek Tetra (previously Supemtek)
Aliases
N/ANo risk management plan link.
